	Integrative analysis of TCGA data identifies hsa-miR-200a as a breast cancer-associated microRNA biomarker with exploratory serum validation. Genes Genomics Park K, Kim EY, Lee EJ, Nam H, Park HW, Lee EH, Kim H, Lee KE, Jeon D, Kim J. PMID: 42560646 [PubMed - as supplied by publisher]
	Prognostic value of post-neoadjuvant pathological response and residual disease in early breast cancer: a real-world cohort study. Clin Transl Oncol Ferro A, Campora M, Eccher C, Lorenzi M, Biondi R, Caldara A, Cantarelli S, Campregher M, Carbone G, De Lisi D, Dipasquale M, Lazzeri S, Monteverdi S, Armatura G, De Rose F, Gori S, Valentini M, Caffo O. PMID: 42560581 [PubMed - as supplied by publisher]
	CDK4/6 Inhibitors in Breast Cancer Therapy: Mechanisms, Resistance, and Emerging Opportunities. Target Oncol Chinea L, Hauer C, Pal K, Chang HL, Chan IS. PMID: 42560566 [PubMed - as supplied by publisher]
	P-VERIFY: Real-World Comparative Overall Survival and Progression-Free Survival of CDK4/6 Inhibitors Plus an Aromatase Inhibitor in Patients with HR+/HER2- Metastatic Breast Cancer in the USA-A Vodcast. Target Oncol Rugo HS, Ryan JC. PMID: 42560565 [PubMed - as supplied by publisher]
	Optimising screening intervals and BI-RADS management pathways in ultrasound-based breast cancer screening: real-world evidence from Shenzhen (2018-2023). Breast Cancer Res Treat Sun W, Li H, Zhao X, Hu S, Qi H, Jin S, Zhang W, Zhao F. PMID: 42560548 [PubMed - indexed for MEDLINE]
	Commissioning and clinical positioning assessment of a novel surface-guided radiation therapy (SGRT) system at a C-Arm linear accelerator. J Appl Clin Med Phys Looe HK, Bartner NFH, Poppe B, Willborn KC. PMID: 42560082 [PubMed - indexed for MEDLINE]
	Direct Hospital Costs of Ambulatory versus Inpatient Needle-Localized Breast Biopsy: A Retrospective Cohort Study. Breast Care (Basel) Thong-Aek CS, Sungworawongpana C, Samphao S, Mahattanobon S, Noonpradej S, Chaochankit W. PMID: 42559575 [PubMed - as supplied by publisher]
	Trop2-targeted PET/CT imaging with (68)Ga-MY6349 improves diagnostic accuracy and influences clinical management in breast cancer. Theranostics Yu L, Zhao L, Zeng R, Su Y, Wu Z, Yu S, Li Y, Fu H, Guo W, Sun Y, Gao H, Sun L, Wu H, Ye F, Wang F, Chen H. PMID: 42559486 [PubMed - indexed for MEDLINE]
	Liquid biopsy in breast cancer: current biomarker platforms and clinical applications. Explor Target Antitumor Ther Podder PS, Bhadra D, Martinelli C, Cortellino S, Giordano A, Cinti S. PMID: 42558869 [PubMed]
	Informing mobile health strategies: Study of mobile phone ownership among rural women for breast cancer control in Ghana. Digit Health Boamah Mensah AB, Mensah KB, Agbeko AE, Mohammed A, Okyere J, Dodd C, Horvath K, Virnig B, Clegg-Lamptey JN, Kulasingam S. PMID: 42558772 [PubMed]
	Secondhand smoke and breast health awareness among Vietnamese American families in California: A mixed-methods study. Tob Prev Cessat Huh J, Tran VH, Galimov A, Truong AN, Ceasar RC, Palinkas LA, Tran T. PMID: 42558697 [PubMed]
	Cell competition within breast tumor microenvironment: emerging role of cancer stem cells and immune cells in tumor progression and therapeutic implications. Front Oncol Pal E, Chakraborty S, Guha A. PMID: 42558596 [PubMed]
	Establishment and evaluation of novel prognostic biomarkers based on systemic coagulation-inflammation index and related genes in breast cancer. Front Immunol Li F, Gao T, Xia J, Wang J, Su Q, Chen Y, Ba Y, Jia S, Li Z, Wang Y, Xiao M. PMID: 42558555 [PubMed - indexed for MEDLINE]
	SPRAYDYE: a phase I/II randomised pilot study to assess the safety and feasibility of topically applied AKRO-6qcICG, a cathepsin-activatable fluorescent imaging agent, for real-time intraoperative resection margin assessment in breast-conserving surgery. Front Surg Pesch CMW, Linders DGJ, March TL, Pool M, Valentijn ARPM, Hilling DE, Walker E, Straight B, Mieog S, Liefers GJ, Cohen D, Hazelbag HM, Straver ME, Basilion JP, Rissmann R, Burggraaf J, Vahrmeijer AL. PMID: 42558486 [PubMed]
	Knowledge, attitudes, and practice in breast cancer early detection: evidence from a nationally stratified study of healthcare providers in Jordan. Front Public Health ALSalamat H, Qtaishat E, Jardaneh D, Al-Hadid M, Al-Ajlouni R. PMID: 42558454 [PubMed - indexed for MEDLINE]
	Advances and challenges in biomarker guided management of triple-negative breast cancer in the era of neoadjuvant chemo-immunotherapy. Front Oncol D'Amato M, Morritti M, Morelli F, Ciuffreda L, Castelvetere M, Mangiacotti FP, Pasculli B, Parrella P. PMID: 42558411 [PubMed]
	Logistic regression-based model for differential diagnosis between plasma cell mastitis and non-mass type breast cancer. Front Oncol Gao Q, Li J, Xia C. PMID: 42558310 [PubMed]
	Case Report: From standard therapy refusal to rare metastases: a case of untreated HER2-positive breast cancer progressing to brain and thyroid metastases after seven years of follow-up during which the patient received only Chinese herbal medicine. Front Oncol Yu Q, Zhang J, Li H, He K. PMID: 42558245 [PubMed]
	Epidermoid Cyst of the Breast With Ultrasonographic Manifestation: A Case Report. J Clin Ultrasound Ouyang H, Zhong X, Huang X, Xu X. PMID: 42557910 [PubMed - as supplied by publisher]
	Decoding Intratumoral Heterogeneity in Breast Cancer: The Evolution From Radiomics to Topological Quantification for Predicting Lymphovascular Invasion. Cancer Control Zuo Z, Li Y, Zeng Y. PMID: 42557854 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 220842

Page 1 of 11043



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy